Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Trillium Therapeutics Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by Baylor1965on Oct 11, 2011 11:10am
448 Views
Post# 19136796

My theory is continue to prove itself

My theory is continue to prove itselfThe fiduciary duty of the SCT' management is to manage the company on behalf of its shareholders. That includes being as transparent as the SEC allows you to be. Did anybody catch the small detail ( in the AGM, news release, videos etc...) that the stroke study has been withdrawn? I didn't, do you know why? They forgot to mention it. WTF?

https://clinicaltrials.gov/ct2/show/NCT00715364?term=%22stem+cell+therapeutics+corp%22&rank=3

This is starting to smell real fishy.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities